Form 4: H.B. Fuller Executive VP and CFO Reports Acquisition of Phantom Units

Sentiment:

SEC Form 4


John J. Corkrean, Executive VP and CFO of H.B. Fuller, reports the acquisition of phantom units convertible into common stock.

Summary

  • John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in beneficial ownership.
  • The report includes the acquisition of 103.32 phantom units on April 12, 2024, which convert into common stock on a 1-for-1 basis.
  • Corkrean directly owns 47,187 shares of common stock.
  • He also holds various employee stock options and restricted stock units with different vesting schedules and expiration dates.

Sentiment

Score: 5

Explanation: This is a routine filing, so the sentiment is neutral.

Positives

  • The reporting person's holdings include a mix of stock, options, and restricted stock units, aligning their interests with shareholders.
  • The vesting schedules of the options and restricted stock units incentivize long-term performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.

Stakeholder Impact

  • The filing provides transparency to shareholders regarding the executive's holdings and incentives.

Key Dates

DateDescription
05/17/2017Date of exercisability for employee stock options at $43.48, expiring on 05/17/2026
01/26/2018Date of exercisability for employee stock options at $50.1, expiring on 01/26/2027
01/25/2019Date of exercisability for employee stock options at $53.57, expiring on 01/25/2028
01/24/2020Date of exercisability for employee stock options at $45.05, expiring on 01/24/2029
01/24/2021Date of exercisability for employee stock options at $48.35, expiring on 01/24/2030
01/27/2022Date of exercisability for employee stock options at $51.89, expiring on 01/27/2031
01/24/2023Date of exercisability for employee stock options at $72.94, expiring on 01/24/2032, and start of vesting for restricted stock units expiring on 01/24/2025
01/24/2024Date of exercisability for employee stock options at $68.17, expiring on 01/24/2033, and start of vesting for restricted stock units expiring on 01/24/2026
01/26/2025Date of exercisability for employee stock options at $77.72, expiring on 01/26/2034, and start of vesting for restricted stock units expiring on 01/26/2027
04/12/2024Date of transaction for the acquisition of 103.32 phantom units.
04/15/2024Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.